Brooks Laboratories Share Price
64.99+0.84 (+1.31%)
-53.11% past 1 Year
Brooks Laboratories Limited (Brooks Laboratories) is a pharmaceutical contract research and manufacturing services company. It provides range of products catering to critical care segment in Parental Section, such as Beta
Corporate filings & documents
Announcements
Proceedings of the 24th AGM held on Thursday September 3 2026.
20 hours agoProceedings of the 24th AGM held on Thursday September 3 2026.
20 hours agoPlease find enclosed herewith Addendum to the Notice of 24th Annual General Meeting.
1 week agoPlease find enclosed herewith Addendum to the Notice of 24th Annual General Meeting.
1 week agoPlease find attached addendum to the notice of 24th Annual General Meeting.
1 week agoPlease find attached addendum to the notice of 24th Annual General Meeting.
1 week agoAddendum to the Notice of 24th Annual General Meeting of the Company.
1 week agoAddendum to the Notice of 24th Annual General Meeting of the Company.
1 week agoIntimation of Record date E-Voting dates and Book Closure date.
2 weeks agoIntimation of Record date E-Voting dates and Book Closure date.
2 weeks agoNewspaper publication dated 14th August 2026 of Unaudited Financial Results for the quarter ended 30th June 2026.
2 weeks agoNewspaper publication dated 14th August 2026 of Unaudited Financial Results for the quarter ended 30th June 2026.
2 weeks agoFinancial Results for quarter ended June 30 2026.
3 weeks agoFinancial Results for quarter ended June 30 2026.
3 weeks agoOutcome of Board Meeting held on Thursday 13th August 2026
3 weeks agoOutcome of Board Meeting held on Thursday 13th August 2026
3 weeks agoNewspaper publication regarding 24th AGM of the Company to be held on 3rd September 2026.
3 weeks agoNewspaper publication regarding 24th AGM of the Company to be held on 3rd September 2026.
3 weeks agoLetter to the Shareholders-Annual Report for the FY 2025-26
3 weeks agoLetter to the Shareholders-Annual Report for the FY 2025-26
3 weeks agoNotice of 24th Annual General Meeting of the Company to be held on 3rd September 2026 through VC/OAVM.
3 weeks agoNotice of 24th Annual General Meeting of the Company to be held on 3rd September 2026 through VC/OAVM.
3 weeks agoPursuant to Regulation 34 read with Regulation 30 of SEBI Listing Regulations we are enclosing herewith the following: 1. Notice of the AGM.2. Annual Report for the Financial Year 2025-26.
3 weeks agoPursuant to Regulation 34 read with Regulation 30 of SEBI Listing Regulations we are enclosing herewith the following: 1. Notice of the AGM.2. Annual Report for the Financial Year 2025-26.
3 weeks agoNewspaper Advertisement - Intimation of 24th Annual General Meeting of the Company through VC/OAVM.
3 weeks agoNewspaper Advertisement - Intimation of 24th Annual General Meeting of the Company through VC/OAVM.
3 weeks agoBrooks Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve and take on record the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30 2026 alongwith Limited Review Report thereon.
4 weeks agoBrooks Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve and take on record the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30 2026 alongwith Limited Review Report thereon.
4 weeks agoAppointment of Mr. Rajesh Mahajan as President - Trading.
1 month agoAppointment of Mr. Rajesh Mahajan as President - Trading.
1 month agoWe hereby inform that further to the disclosure made by the Company on 19th June 2026 regarding proposed sale of a portion of its shareholding in Brooks Steriscience Limited.
1 month agoWe hereby inform that further to the disclosure made by the Company on 19th June 2026 regarding proposed sale of a portion of its shareholding in Brooks Steriscience Limited.
1 month agoCertificate under Regulation 74(5) of SEBI (DP) Regulation 2018 for quarter ended 30th June 2026.
1 month agoCertificate under Regulation 74(5) of SEBI (DP) Regulation 2018 for quarter ended 30th June 2026.
1 month agoIntimation of Incorporation of Wholly Owned Subsidiary.
2 months agoIntimation of Incorporation of Wholly Owned Subsidiary.
2 months agoIntimation of Closure of Trading Window.
2 months agoIntimation of Closure of Trading Window.
2 months agoWith reference to corporate announcement titled "Partial Sale of Equity Shares held in Brooks Steriscience Limited" submitted by the Company on 19th June 2026 we wish to inform you that the Company has received email from BSE Limited seeking additional details.
2 months agoWith reference to corporate announcement titled "Partial Sale of Equity Shares held in Brooks Steriscience Limited" submitted by the Company on 19th June 2026 we wish to inform you that the Company has received email from BSE Limited seeking additional details.
2 months agoWe hereby inform that the Company at its board meeting held today i.e 19th June 2026 has approved sale of 51 220 equity shares held by the Company in Brooks Steriscience Limited to Steriscience Specialities Limited.
2 months agoWe hereby inform that the Company at its board meeting held today i.e 19th June 2026 has approved sale of 51 220 equity shares held by the Company in Brooks Steriscience Limited to Steriscience Specialities Limited.
2 months agoNewspaper Publication dated 30th May 2026 of Audited Financial Results for the quarter and year ended 31st March 2026.
3 months agoAnnual Secretarial Compliance Report of the financial year ended 31st March 2026
3 months agoAppointment of Chief Executive Officer.
3 months agoAppointment of Chief Executive Officer.
3 months agoOutcome of Board Meeting held on Held On Friday 29th May 2026.
3 months agoOutcome of Board Meeting held on Held On Friday 29th May 2026.
3 months agoOutcome of the Board Meeting held on Friday 29th May 2026
3 months agoBrooks Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve and take on record the Audited Financial Results (Standalone and Consolidated) for the quarter and Financial Year ended March 31 2026 along Auditors Report thereon.
3 months agoAnnual reports
Concalls & investor presentations
No presentations found
Corporate Actions
Date
Type
Details
2023-07-28
Rights
1:16;75.0 (Rights ratio;Offer price)
Company details
Registered office
Village Kishanpura Nalagarh Road Baddi Solan Dist Himachal Pradesh PIN: 174101 Tel No: 01795-654001/02/03 Fax No: 01795-236939 Email: [email protected] / [email protected] Internet: www.brookslabs.net
Registrars
C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra C 101, 247 Park LBS Marg Vikhroli (West) PIN: Tel No: +91 810 811 8484 Fax No: 91-022-49186060 Email: [email protected] Internet: https://in.mpms.mufg.com/
Management
Krutika Mohan Rane, Company Secretary & Compliance Officer
Bhushan Singh Rana, Whole Time Director
Jitendra Pratap Singh, Whole Time Director
Durga Shankar Maity, Whole Time Director
Usha Singh, Non Executive Independent Director
Lalit Mahajan, Non Executive Independent Director
Manav Mahajan, Non Executive Independent Director
Details
BSE 533543
NSE BROOKS
ISIN INE650L01011